Abstract:Objective This study evaluates the impact of different combinations of treatment regimens, such as additional radiation, chemotherapy, and surgical treatments, on the survival of elderly rectal cancer patients ≥ 70 years of age to support physicians' clinical decision-making. Methods Data from a sample of elderly rectal cancer patients aged ≥ 70 years diagnosed from 2005–2015 from the US surveillance, epidemiology, and end results (SEER) database were retrospectively analyzed. The best cut-off point was selected using the x-tile software for the three continuity indices: age, tumor size, and number of regional lymph nodes. All patients were categorized into either the neoadjuvant radiotherapy and surgery group (R_S group), the surgical treatment group (S group), or the surgery and adjuvant radiotherapy group (S_R group). The propensity score allocation was used to match each included study subject in a 1:1 ratio, and the restricted mean survival time method (RMST) was used to predict the mean survival of rectal cancer patients within 5 and 10 years. The prognostic risk factors for rectal cancer patients were determined using univariate and multivariate Cox regression analyses, and nomograms were constructed. A subgroup stratification analysis of patients with different treatment combination regimens was performed using the Kaplan-Meier method, and log-rank tests were used for between-group comparisons. The model's predictive accuracy was assessed by receiver operating characteristic (ROC) curves, correction curves, and a clinical decision curve analysis (DCA). Results A total of 7556 cases of sample data from 2005 to 2015 were included, which were categorized into 6639 patients (87.86%) in the S group, 408 patients (5.4%) in the R_S group, and 509 patients (6.74%) in the S_R group, according to the relevant order of radiotherapy and surgery. After propensity score matching (PSM), the primary clinical characteristics of the groups were balanced and comparable. The difference in the mean survival time before and after PSM was not statistically significant in both R_S and S groups (P value > 0.05), and the difference in the mean survival time after PSM was statistically substantial in S_R and S groups (P value < 0.05). In the multifactorial Cox analysis, the M1 stage and Nodes ≥ 9 were independent risk factors. An age between 70–75 was an independent protective factor for patients with rectal cancer in the R_S and S groups. The Marital_status, T4 stage, N2 stage, M1 stage, and Nodes ≥ 9 were independent risk factors for patients with rectal cancer in the S_R and S groups, and an age between 70–81 was an independent protective factor. The ROC curve area, the model C index, and the survival calibration curve suggested good agreement between the actual and predicted values of the model. The DCA for 3-year, 5-year, and 10-year survival periods indicated that the model had some potential for application. Conclusions The results of the study showed no significant difference in the overall survival (OS) between elderly patients who received neoadjuvant radiotherapy and surgery and those who received surgery alone; elderly patients who received surgery and adjuvant radiotherapy had some survival benefits compared with those who received surgery alone, though the benefit of adjuvant radiotherapy was not significant. Therefore, radiotherapy for rectal cancer patients older than 70 years old should be based on individual differences in condition, and a precise treatment plan should be developed.

Survival Analysis of Radiation Therapy in Ovarian Cancer: A SEER Database Analysis

Radiotherapy Improves The Survival Of Patients With Metastatic Cervical Cancer A Propensity-Matched Analysis Of Seer Database

Adjuvant Pelvic Radiotherapy in Ovarian Cancer: Outcomes By Risk Factors

Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer

Effects of Postoperative Radiotherapy in Early Breast Cancer Patients Older Than 75 Years: A Propensity-Matched Analysis

Stage IIB-IVA Cervix Carcinoma in Elderly Patients Treated with Radiation Therapy: a Longitudinal Cohort Study by Propensity Score Matching Analysis

Early-stage Ovarian Immature Teratoma, Surveillance, or Chemotherapy after Surgery? A Propensity Score Matched Analysis

131O Radiotherapy Improves the Survival of Patients with Stage IV Non-Small Cell Lung Cancer: A Propensity Matched Analysis of Surveillance, Epidemiology, and End Results Database

A retrospective study on the impact of radiotherapy on the survival outcomes of small cell lung cancer patients based on the SEER database

Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database

Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy, And Other Factors Associated With The Prognosis Of Early Breast Cancer Treated With Breast-Conserving Surgery And Radiotherapy: A Retrospective Study From Seer Database

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database.

Effect of Radiotherapy on the Survival of Cervical Cancer Patients

Analysis of the impact of radiotherapy and surgical treatment regimens based on the SEER database on the survival outcomes of rectal cancer patients over 70 years

Survival Analysis of Ovarian Cancer Patients with Distant Metastasis after Chemotherapy: A SEER-based Study.

Is Prophylactic Radiotherapy to the Lymphatic Drainage Area Necessary for Patients With Stage III Ovarian Cancer After Chemotherapy Following Surgery?

Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients

Prognostic Role of Radiotherapy in Low-Risk Elderly Breast Cancer Patients after Breast-Conserving Surgery: a Cohort Study

Survival after intraoperative or postoperative radiotherapy in early breast cancer: an analysis of the SEER database

Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study

Analysis of Treatment Outcome and Prognosis of Elderly Patients with Advanced Epithelial Ovarian Cancer